Why doctors don't think vaccine skeptics' acceptance of a helpful COVID-19 treatment is sufficient
Monoclonal antibodies produced by Regeneron and Eli Lilly have become widely accepted as a successful treatment for COVID-19, reducing symptoms quickly and keeping infected people out of the hospital if they act quickly enough. Doctors and vaccine skeptics alike are proponents, but some medical experts argue the antibodies aren't enough on their own to make up for the slow-down in vaccine uptake, The New York Times reports.
The simple explanation is that the more people who get vaccinated, the fewer people there will be who need any sort of coronavirus remedy. Beyond that, the infusions also take a lot of time and require a lot of attention from hospital staff. They're also more expensive, costing the federal government about $2,100 per dose. "It's clogging up resources, it's hard to give, and a vaccine is $20 and could prevent almost all of that," Dr. Christian Ramers, an infectious disease specialist and the chief of population health at Family Health Centers of San Diego, told the Times. Basically, Ramers said, emphasizing monoclonal antibodies and playing down vaccines is akin to "investing in car insurance without investing in brakes."
The other worry is that they can't keep up with the pace of more serious outbreaks. For starters, the treatments only help individual patients, whereas vaccines have a snowball effect, and they also don't provide protective immunity (though the patients would have acquired natural immunity through their infection), the Times notes. Ultimately, while monoclonal antibodies are a vital tool in fighting the coronavirus, "something like that just doesn't scale," Dr. Howard Huang, the medical leader for Houston Methodist's infusion program, told the Times. Read more at The New York Times.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
'Virtual prisons': how tech could let offenders serve time at home
Under The Radar New technology offers opportunities to address the jails crisis but does it 'miss the point'?
By Chas Newkey-Burden, The Week UK Published
-
The Week contest: Airport goodbyes
Puzzles and Quizzes
By The Week US Published
-
'We shouldn't be surprised that crypto is back'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Israel, UN agree to Gaza pauses for polio vaccinations
Speed Read Gaza's first case of polio in 25 years was confirmed last week in a 10-month-old boy who is now partially paralyzed
By Rafi Schwartz, The Week US Published
-
WHO declares mpox a global health emergency
Speed Read An outbreak of the viral disease formerly known as monkeypox continues to spread in Africa
By Rafi Schwartz, The Week US Published
-
Have we defeated malaria?
The Explainer Roll-out of low-cost vaccine means a world free from disease that claims 600,000 lives a year 'finally within sight'
By The Week UK Published
-
Roll-out of affordable malaria vaccine begins
Speed Read R21 is approved for babies and may save hundreds of thousands of lives
By Arion McNicoll, The Week UK Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published